Curebase
ActiveModern, AI-powered clinical trial software platform.
About
Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC.
From their website
www.curebase.ai ↗Curebase offers a modern eClinical platform that integrates ePRO/eCOA, eConsent, EDC, recruitment, and site software to streamline clinical trials. The platform emphasizes AI-powered tools to accelerate study startup, improve data quality, and keep participants engaged.
The platform provides integrated modules for ePRO/eCOA, eConsent, electronic data capture (EDC), participant recruitment, and site software (Sitebase) to manage study startup through database lock. It includes a mobile-first participant app for engagement, a site portal to streamline operations and workflows, and AI-powered trial capabilities to support data quality and accelerated timelines. Users can explore and trial the platform via an interactive demo without sign-up, and Curebase positions the platform as adaptable for biotech, MedTech, Pharma, and CROs.
Who it’s for: Biotech startups, MedTech companies, pharmaceutical companies, and CROs or organizations managing multiple sponsors and studies.
- ePRO/eCOA data capture
- eConsent management
- Electronic Data Capture (EDC)
- Participant recruitment tools
- Site management portal
- Mobile-first participant experience
- AI-powered trial capabilities
Pricing page mentions; interactive demos available; notable emphasis on AI-powered features and adoption by biotech/medtech/pharma/CROs
Founders · 1
Co-founder and CEO of Luminist Labs (Acquired by DiscernDx) Currently CEO @ Curebase (S18)
Formerly “tlemberg”
Related startups
We grow cells for biotech companies.
Enabling next generation medicines. A comprehensive platform and…
